Serina Therapeutics (SER) Return on Sales (2018 - 2025)
Historic Return on Sales for Serina Therapeutics (SER) over the last 8 years, with Q3 2025 value amounting to 201.69%.
- Serina Therapeutics' Return on Sales rose 1788800.0% to 201.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 201.69%, marking a year-over-year decrease of 1979100.0%. This contributed to the annual value of 313.82% for FY2024, which is 3126500.0% down from last year.
- Per Serina Therapeutics' latest filing, its Return on Sales stood at 201.69% for Q3 2025, which was up 1788800.0% from 42.88% recorded in Q2 2025.
- Serina Therapeutics' Return on Sales' 5-year high stood at 397.57% during Q4 2024, with a 5-year trough of 541.4% in Q1 2022.
- Its 5-year average for Return on Sales is 149.49%, with a median of 81.82% in 2024.
- In the last 5 years, Serina Therapeutics' Return on Sales plummeted by -5395600bps in 2022 and then surged by 5064700bps in 2023.
- Quarter analysis of 5 years shows Serina Therapeutics' Return on Sales stood at 0.72% in 2021, then tumbled by -48133bps to 345.0% in 2022, then skyrocketed by 100bps to 0.02% in 2023, then skyrocketed by 1888058bps to 397.57% in 2024, then crashed by -151bps to 201.69% in 2025.
- Its Return on Sales was 201.69% in Q3 2025, compared to 42.88% in Q2 2025 and 410.29% in Q1 2025.